|
|
||||||||
Memorial Sloan-Kettering Cancer Center, New York, New York
Correspondence: For reprints contact: Samuel Yeh, Nuclear Medicine Service, Memorial Sloan-Kettering Cancer Ctr., 1275 York Ave., New York, NY 10021.
ABSTRACT
When Tc-99m-labeled methylene diphosphonate was used 4.75 hr after reconstitution, stomach concentration was seen in the majority of patients. The number of patients with stomach concentration increases with time and is associated with the increasing amount of product breakdown. The reconstituted labeled MDP should not be used after 45 hr if stomach concentration is to be avoided.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |